Member Spotlight / News - September 5, 2024
Every month, EUCOPE spotlights a member company and the great work it’s doing to advance the life sciences industry and drive innovation to serve patients better. This September, we spoke with Mike Ryan, Manager, Europe, EVERSANA. Mike Ryan has worked across the life sciences and… read more
News - July 19, 2024
EUCOPE congratulates Ursula von der Leyen on the confirmation of her second term as President of the European Commission. Her leadership and commitment to public health have been instrumental in steering Europe through challenging times. It is now fundamental to build on these accomplishments, delivering… read more
News / Press Releases - June 25, 2024
The European Confederation of Pharmaceuticals Entrepreneurs (EUCOPE) announced the joining of 7 new members at its quarterly Members Meeting on 18 June 2024, following Board approval. The new members joining the EUCOPE network are Acadia, Edelman Global Advisory, Elevate Bio, GE Healthcare, Regeneron, Rhythm Pharmaceuticals and… read more
News / Press Releases - June 21, 2024
At the Employment, Social Policy, Health and Consumer Affairs Council (EPSCO) meeting on 21 June, Health Ministers adopted Council Conclusions on the Future of the European Health Union. Presenting the Council’s perspective on the forthcoming EU health agenda, the Conclusions outline strategic priorities and actions… read more
News / Press Releases - June 11, 2024
The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) extends its heartfelt congratulations to the newly elected Members of the European Parliament (MEPs). As the key representative body for predominantly small and medium-sized innovative pharmaceutical companies in Europe, EUCOPE recognises the pivotal role MEPs play in shaping… read more
News / Press Releases - June 6, 2024
The Regulation on Substances of Human Origin (SoHO) has been officially adopted by the EU Institutions, following the European Parliament’s approval on 24 April and the formal adoption by the Council of the European Union on 27 May. The new Regulation aims to improve the… read more
News / Press Releases - June 5, 2024
In June 2024, the Cancer Patients Europe, the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), the European Society of Pathology and Lung Cancer Europe (LuCE) published a joint statement on increasing access to genomic testing, delivering on the ambitions of Europe’s Beating Cancer Plan. Over the past 10 years,… read more
News / Partnerships / Press Releases - May 17, 2024
On 16 May 2024, EUCOPE signed EURORDIS Open Letter #ActRare2024, during the Closing Plenary session of the 12th European Conference on Rare Diseases and Orphan Products (ECRD), organised in Brussels on 15-16 May 2024. The Open Letter is a result of, and informed by, the… read more
EUCOPE Resources / News - May 6, 2024
EUCOPE’s Sounds of Science Podcast – Episode 18 The Revision of the General Pharmaceutical Legislation: European Parliament Reports In this episode of Sounds of Science, we explore the ongoing Revision of the General Pharmaceutical Legislation (GPL). On 10 April, the European Parliament adopted their reports… read more
News / Press Releases - April 26, 2024
On 25 April 2024, EUCOPE signed a Joint Statement on the European Commission’s Initiative “Boosting Biotechnology and Biomanufacturing in the EU”, together with key industry associations and organisations representing biotechnology across sectors. While focusing on the entire biotech sector, the Communication recognises the important role… read more
